Page last updated: 2024-10-22

amlodipine and Cardiomyopathy, Hypertrophic Obstructive

amlodipine has been researched along with Cardiomyopathy, Hypertrophic Obstructive in 1 studies

Amlodipine: A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION.
amlodipine : A fully substituted dialkyl 1,4-dihydropyridine-3,5-dicarboxylate derivative, which is used for the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina.

Research Excerpts

ExcerptRelevanceReference
"The prognosis of dilated cardiomyopathy(DCM) has improved due to advances in earlier diagnosis and therapy, however, sudden cardiac death and death from congestive heart failure still occur in DCM."2.41[Prognosis of hypertrophic and dilated cardiomyopathy]. ( Ikeda, H; Imaizumi, T, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ikeda, H1
Imaizumi, T1

Reviews

1 review available for amlodipine and Cardiomyopathy, Hypertrophic Obstructive

ArticleYear
[Prognosis of hypertrophic and dilated cardiomyopathy].
    Nihon rinsho. Japanese journal of clinical medicine, 2000, Volume: 58, Issue:1

    Topics: Adrenergic beta-Antagonists; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel B

2000